Is GSK a good dividend stock?
Analysts expect the stock’s EPS to grow at a 4.4% rate per annum over the next five years. GSK distributes $2.17 in dividends annually, which translates to a 5.18% dividend yield. The company’s dividend has grown at a 5.4% rate over the past four years.
Is GSK a safe stock?
In aggregate, GlaxoSmithKline currently has a Value Score of A, putting it into the top 20% of all stocks we cover from this look. This makes GlaxoSmithKline a solid choice for value investors, and some of its other key metrics make this pretty clear too.
Is GSK dividend sustainable?
As a great dividend stock, GlaxoSmithKline has two things going for it: consistent growth and a high but sustainable yield. The 6.6% yield it boasted in 2015 may not be back for a while, but the current yield gives the dividend room to grow.
Is GSK a good buy?
According to the Financial Times, five analysts rate GSK stock a buy; six say Glaxo’s share price has the potential to outperform the market in the next 12 months; 16 have a hold rating in place; and two say GSK shares will underperform. There are no sell ratings.
Did GSK cut dividend?
Glaxo (ticker: GSK) said that the combined dividend from the stay-behind company, referred to as New GSK, and the consumer health spinoff would be approximately 55 pence per share in 2022, a 31% reduction from the 2021 dividend. … Glaxo shares were up 2.3% at 10:42 a.m. Wednesday. On a media call early Wednesday.
Will Glaxo cut dividend?
GlaxoSmithKline (GSK) boss Dame Emma Walmsley has attempted to hold off investor pressure with a new strategy announcement today, promising a “step-change in growth and performance” at the healthcare giant. However the pharma giant will cut its dividend to invest more in its drugs pipeline.
Is GSK stock a buy or sell?
For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25).
Momentum Scorecard. More Info.
|Zacks Rank||Definition||Annualized Return|
Is GSK a Buy Sell or Hold?
GlaxoSmithKline PLC holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
What is the dividend for GSK?
GSK Dividend History
|Ex/EFF DATE||TYPE||CASH AMOUNT|
How much will GSK cut dividend?
The dividend will be cut to 55 pence in 2022 — an aggregate number that includes some contribution from the consumer business. The payment from New GSK will be 45 pence in 2023.
Is GlaxoSmithKline a dividend aristocrat?
UK Dividend Aristocrat #5: GlaxoSmithKline Plc.
GSK is to split itself in two by demerging its consumer products division. A demerger can create value for shareholders (the 1+1 = 3 part) but GSK is asking investors to trust that this plays out while also having to accept a much lower dividend (the ‘-½’ part).
Is GSK a UK company?
GlaxoSmithKline (GSK), formerly Glaxo Wellcome, British-based pharmaceutical company with research-and-development centres in the United States, Belgium, and China as well as the United Kingdom.